
Please try another search
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Name | Age | Since | Title |
---|---|---|---|
Asaf Itzhaik | 52 | 2024 | Independent Director |
Liat Sidi | 49 | 2024 | Independent Director |
Avi Schroeder | - | 2021 | Member of Scientific Advisory Board |
Fabio Sonvico | - | 2021 | Member of Scientific Advisory Board |
Oz Adler | 38 | 2021 | Director |
Liron Carmel | 40 | - | Independent Director |
Smadar Cohen | - | 2005 | Member of Scientific Advisory Board |
Nancy Agmon-Levin | - | 2022 | Member of Scientific Advisory Board |
Yehonatan Zalman Vinokur | 46 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review